Photo: Radovanovic96/Getty Images
GE HealthCare unveiled Pristina Via, a mammography system aimed at enhancing the screening experience for technologists and patients.
Pristina Via gives mammography technologists a suite of tools that balance the demands of diagnostic accuracy and fast-moving workflows to expedite more patient-centered breast care.
As part of the Senographe Pristina platform, Pristina Via brings features to help reduce repetitive tasks and simplify workflows so mammography technologists can focus on providing quality and individualized care during the screening process.
The company says that no wait time between exposures permits technologists to operate at their own pace, while vendor-neutral prior image comparison reduces the time spent analyzing previous exams, so making final assessments more efficient.
"Pristina Via represents a significant evolution in our patient focused Senographe Pristina platform which was designed by women for women. With the new in-room workflow, Pristina Via minimizes laborious tasks and provides technologists with the gift of time to prioritize what matters most: compassionate, patient-centered care," Jyoti Gupta, president and CEO for Women’s Health and X-ray at GE HealthCare, said in a statement.
THE LARGER TREND
Earlier this month, GE HealthCare and DeepHealth, a subsidiary of RadNet, collaborated on new AI imaging technology to further innovation, commercialization and adoption of AI in imaging.
The companies codeveloped SmartTechnology, which are tools that employ AI to address key obstacles across the imaging value chain, like helping increase the efficiency of imaging interpretation and reporting, allowing collaboration across care teams, improving the clinical interpretation of images and strengthening operational efficiency and productivity.
In October, GE HealthCare unveiled CareIntellect for Oncology, a cloud application that joins multimodal patient data from different systems into a single view with the help of generative AI to give clinicians access to notes and reports.
In July, GE HealthCare announced it formed a strategic partnership to use Amazon Web Services (AWS) healthcare and genAI services to create AI-enabled workflows that help improve the accuracy of diagnostic screening, streamline healthcare operations and improve equitable care access and outcomes.
GE will use Amazon Bedrock's foundation models to create its own proprietary genAI applications and modernize its applications built on Amazon SageMaker. The company's developers will also use Amazon Q, an AI-powered assistant, to generate code suggestions and assist in software development.
In September, Siemens Healthineers, GE HealthCare's competitor in the mammography space, received premarket approval from the FDA for the tomosynthesis or three-dimensional breast imaging technology of the Mammomat B.brilliant.
The approval included new 3D image acquisition and image reconstruction technology and added to the system’s already-cleared features for full-field digital mammography, or two-dimensional breast imaging, breast biopsy and titanium contrast-enhanced mammography.
